
1. faseb j. 2012 oct;26(10):3969-79. doi: 10.1096/fj.11-201384. epub 2012 jun 22.

cell-penetrating anti-gfap vhh corresponding fluorescent fusion protein
vhh-gfp spontaneously cross blood-brain barrier specifically recognize
astrocytes: application brain imaging.

li t(1), bourgeois jp, celli s, glacial f, le sourd am, mecheri s, weksler b,
romero i, couraud po, rougeon f, lafaye p.

author information: 
(1)platform: production de protéines recombinantes et d’anticorps-proteopole,
unité genes, synapses, et cognition, centre national de la recherche scientifique
(cnrs), institut pasteur, 25 rue du dr roux, 75724 paris cedex 15, france.

antibodies normally cross blood-brain barrier (bbb) cannot bind an
intracellular cerebral antigen. demonstrate first time new
class antibodies cross bbb without treatment. camelids produce native 
homodimeric heavy-chain antibodies, paratope composed a
single-variable domain called vhh. here, used recombinant vhh directed against
human glial fibrillary acidic protein (gfap), specific marker astrocytes.
only basic vhhs (e.g., pi=9.4) able cross bbb vitro (7.8 vs. 0%
for vhh pi=7.7). intracarotid intravenous injections live mice, 
we showed basic vhhs able cross bbb vivo, diffuse into
the brain tissue, penetrate astrocytes, specifically label gfap. to
analyze ability used specific transporter, expressed a
recombinant fusion protein vhh-green fluorescent protein (gfp). these
"fluobodies" specifically labeled gfap murine brain sections, basic
variant (pi=9.3) fusion protein vhh-gfp able cross bbb to
label astrocytes vivo. potential vhhs diagnostic therapeutic
agents central nervous system deserves attention.

doi: 10.1096/fj.11-201384 
pmid: 22730440  [indexed medline]

